WEBINAR ON DEMAND
Duration: 1 hour
As pharmaceutical companies reorient their commercialization strategies around modernized and human-centered design, they need to account for more factors than ever—not only the need to engage with the holistic patient, but also the people who support their care: family members, healthcare providers, advocacy groups, and others.
But how? Learn how Teun Schutte (Hexaware Life Sciences) and Mark de Leeuw (Rhythm Pharmaceuticals) utilized human-centered design to navigate these and other post-launch engagement considerations. Exploring a patient engagement model built for a rare childhood disease as an example, Schutte and de Leeuw will discuss: